Xconomy National

Archives

by in

Entry	Author	Date	Location
Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers	Erin Kutz	01/06/12	Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers	Erin Kutz	12/16/11	Boston
Cerulean Pharma Adds $15M to Further Nano-Drug Platform	Arlene Weintraub	12/15/11	Boston
Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News	Erin Kutz	11/04/11	Boston
Alnylam and Glaxo Partner on RNAi for Vaccine Production	Arlene Weintraub	11/01/11	Boston
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News	Erin Kutz	10/07/11	Boston
RXi Splits Up, Zeo Launches Mobile Sleep-Tracking App, Karuna Licenses Schizophrenia Compounds, & More Boston-Area Life Sciences News	Erin Kutz	09/30/11	Boston
RXi Splits Into Two Public Companies After Adding Cancer Vaccine to Pipeline	Arlene Weintraub	09/26/11	Boston
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News	Bruce V. Bigelow	08/11/11	San Diego
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News	Erin Kutz	07/29/11	Boston
Cerulean Shows Progress in Cancer, Tests Nano-Drug Platform in RNAi	Arlene Weintraub	07/27/11	Boston
Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence	Arlene Weintraub	05/26/11	Boston
Alnylam Inks Deal with Precision NanoSystems	Ryan McBride	04/19/11	Boston
Vertex CF Drug Delivers, Follica Patent Application Reveals Tech, RXi Buys Apthera, & More Boston-Area Life Sciences News	Erin Kutz	04/01/11	Boston
Alnylam Sued By Tekmira, Curis Cancer Drug Shows Results, Still River Gets $11.5M, & More Boston-Area Life Sciences News	Erin Kutz	03/25/11	Boston
Alnylam Named in Complaint Over RNAi Patents	Ryan McBride	03/23/11	Boston
Tekmira-Alnylam Lawsuit Centers on Drug Carrier Particles	Ryan McBride	03/18/11	Boston
Alnylam Settles One Lawsuit, Hit With Another; Living Proof Raises $16M, Tolerx/GSK Drug Fails to Meet Goal, & More Boston-Area Life Sciences News	Rebecca Zacks	03/18/11	Boston
Alnylam, UMass, and Others Settle RNAi Patent Litigation	Ryan McBride	03/15/11	Boston
CHiL Bought by International Rectifier, DynamicOps Gets $11M, NeuroPhage Raises $12M, & More Boston-Area Deals News	Erin Kutz	03/02/11	Boston
Mello’s RXi Pharma to Raise $8.1M	Ryan McBride	03/01/11	Boston
EyeGate Adds $6M to Series D	Erin Kutz	01/06/11	Boston
Alnylam CEO Looks to the Future, Dicerna Plumps Up Kyowa Hakko Pact, Momenta Sells $57.4M Stock Offering, & More Boston-Area Life Sciences News	Erin Kutz	12/10/10	Boston
Dicerna Expands Kyowa Hakko Pact	Ryan McBride	12/07/10	Boston
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News	Erin Kutz	11/19/10	Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News	Erin Kutz	10/22/10	Boston
Dicerna Gets Glaxo’s SR One to Join Investor Syndicate	Ryan McBride	10/21/10	Boston
Alnylam Seeks to Prove RNAi Skeptics Wrong After Layoffs, End of Novartis Deal	Ryan McBride	10/21/10	Boston
5 Biotech Storylines to Watch in Boston	Ryan McBride	10/13/10	Boston
ProNAi Therapeutics Advances Gene-Silencing Cancer Drug, Marina Biotech Provides Delivery Package	Ryan McBride	09/28/10	Detroit
Page 1 of 3	next page »